Ciprofloxacin Resistance in Enterococcus faecalis Strains Isolated From Male Patients With Complicated Urinary Tract Infection

다국어 초록 (Multilingual Abstract)

Purpose: Urinary tract infection (UTI) is one of the most prevalent bacterial infections,and fluoroquinolone therapy is a well-known standard regimen for UTI. The prevalence and risk factor analysis of fluoroquinolone resistance in enterococcal UTIs are not well documented. The aim of this study was to evaluate the antimicrobial susceptibility and risk factors for ciprofloxacin resistance in Enterococcus faecalis strains isolated from patients with complicated UTI.
Materials and Methods: We evaluated 81 E. faecalis strains isolated from 81 male patients at a single teaching hospital over 3 years. The Vitek 2 automatic system was used for antimicrobial susceptibility analysis.
Results: Antimicrobial resistance rates were rare for ampicillin/sulbactam, imipenem,and vancomycin in E. faecalis. Forty-six percent of the E. faecalis strains were resistant to levofloxacin, 47% were resistant to ciprofloxacin, and 58% were resistant to norfloxacin. E. faecalis strains were highly resistant to erythromycin (92%) and ftetracycline (96%). The risk factor analysis revealed that age intervals, the underlying diseases, catheterization, and the number of admissions did not increase the risk of ciprofloxacin resistance, whereas patients with hospital-acquired infection (odds ratio [OR], 18.15; 95% confidence interval [CI], 3.46 to 95.13; p=0.001), patients who were treated in a urological department (OR, 6.15; 95% CI, 1.5 to 25.41; p=0.012), and patients who were transferred from health care centers (OR, 7.393; 95% CI, 1.32 to 41.22;p=0.023) had an increased risk of ciprofloxacin resistance compared with the matched controls.
Conclusions: Ciprofloxacin is no longer a recommended therapy for E. faecalis from complicated UTI in men with risk factors. We suggest that ampicillin/sulbactam can be recommended as alternatives for treating ciprofloxacin-resistant E. faecalis strains associated with UTI in Korea.

참고문헌 (Reference)

1 Orenstein R, "Urinary tract infections in adults" 59 : 1225-1234, 1999

2 Drekonja DM, "Urinary tract infection in male veterans: treatment patterns and outcomes" 173 : 62-68, 2013

3 Lautenbach E, "The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients" 51 : 280-285, 2010

4 Ishikawa K, "The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy" 17 : 126-138, 2011

5 Sibel AK, "The evaluation of antimicrobial susceptibility of urine enterococci with the Vitek 2 automated system in eastern Turkey" 43 : 986-991, 2012

6 Klare I, "Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals" 24 : 815-825, 2005

7 van der Starre WE, "Risk factors for fluoroquinolone- resistant Escherichia coli in adults with community- onset febrile urinary tract infection" 66 : 650-656, 2011

8 Rattanaumpawan P, "Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients" 139 : 955-961, 2011

9 이길호, "Risk Factors for Antimicrobial Resistance Among the Escherichia coli Strains Isolated from Korean Patients with Acute Uncomplicated Cystitis: A Prospective and Nationwide Study" 대한의학회 25 (25): 1205-1209, 2010

10 Smithson A, "Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection" 31 : 423-430, 2012

11 Roghmann MC, "Prevalence and natural history of colonization with fluoroquinolone-resistant gram-negative bacilli in community-dwelling people with spinal cord dysfunction" 87 : 1305-1309, 20

12 Puhto T, "Point prevalence and risk factors for healthcare-associated infections in primary healthcare wards" 39 : 217-223, 2011

13 Sava IG, "Pathogenesis and immunity in enterococcal infections" 16 : 533-540, 2010

14 Klare I, "Occurrence and spread of antibiotic resistances in Enterococcus faecium" 88 : 269-290, 2003

15 Morrison AJ Jr, "Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital" 146 : 1549-1551, 1986

16 Matsumoto T, "Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008)" 37 : 210-218, 2011

17 Huycke MM, "Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future" 4 : 239-249, 1998

18 Yasufuku T, "Mechanisms of and risk factors for fluoroquinolone resistance in clinical Enterococcus faecalis isolates from patients with urinary tract infections" 49 : 3912-3916, 2011

19 Stamm WE, "Management of urinary tract infections in adults" 329 : 1328-1334, 1993

20 Huang CC, "Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010" 40 (40): S4-S10, 2012

21 Peleg AY, "Hospital-acquired infections due to gram-negative bacteria" 362 : 1804-1813, 2010

22 Sood S, "Enterococcal infections & antimicrobial resistance" 128 : 111-121, 2008

23 Goossens H, "ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study" 365 : 579-587, 2005

24 Johansen TE, "Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system" 38 (38): 64-70, 2011

25 Hsueh PR, "Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region" 63 : 114-123, 2011

26 Neal DE Jr., "Complicated urinary tract infections" 35 : 13-22, 2008

27 Horan TC, "CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting" 36 : 309-332, 2008

28 Adam D, "Beta-lactam/beta-lactamase inhibitor combinations in empiric management of pediatric infections" 30 (30): 10A-19A, 2002

29 Hoban DJ, "Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta- lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010" 74 : 62-67, 2012

30 Lee SJ, "Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System" 17 : 440-446, 2011

31 Wagenlehner FM, "An update on uncomplicated urinary tract infections in women" 19 : 368-374, 2009